News

The British Medical Association (BMA) has accused the Health Secretary of being “willfully negligent”.

Givlaari uses ‘gene silencing’ RNA interference technology, to target the production of pathogenic compounds in people AHP

The two parties will jointly generate and evaluate ADC candidates

Lucid-PSYCH is a psychoactive compound potentially viable for the treatment of major depressive disorders

ATDBio adds important platform solutions to Biotage within DNA and RNA oligonucleotide synthesis and purification

Scancell has taken new laboratory and office space in the Bellhouse Building at TOSP

Results are ‘unprecedented’ according to company

This partnership is the latest in an ongoing collaboration between the companies

Interstitial lung disease (ILD) is a termed used to describe a collection of over 200 lung disorders

MindPod pioneers the world’s first immersive neuro-animation experience

Dupilumab (also known as Dupixent) will be available to patients through injections

Under the terms of the agreement, Hansoh will make a $16m upfront payment to Silence

Sensyne and OMNY have agreed to work together on commercial projects for life sciences clients to advance ethical medical research